WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017

Jul 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-06-30

Reporting Person: LAI GOLDMAN MYLA (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-30	Phantom Stock Unit	$	A	105.9434	Acquired		Common Stock (105.9434)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9539.7747	Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F2: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.